Enteric Disease Testing Market Analysis, By Disease Type (Bacterial (C. Difficile, Cholera, E. Coli, H. Pylori, Salmonellosis, Shigellosis), Viral (Rotavirus, Norovirus), Parasitic (Amebiasis, Cryptosporidiosis, Giardiasis), And Segment Forecasts, 2018 - 2025

Industry Insights

The global enteric disease testing market size was valued at USD 3.3 billion in 2016 and is expected to reach USD 4.2 billion in 2025 at a CAGR of 2.5% over the forecast period. Vital drivers of this market include technological advancements and supportive government funding in emerging economies. Furthermore, growing global demand for early diagnostic is expected to enhance the applicability of the market, fueling its growth.

The traditional diagnostic process of enteric diseases was based on the culture method which demanded skilled staff and was time consuming procedure. Development of molecular diagnostics and other diagnostic technologies revolutionized this disease testing market over the last decade. The increasing mortality rate due to these conditions and the cost efficiency of the technologically advanced diagnostic systems are expected to drive the demand for early diagnosis of these conditions.

U.S enteric disease testing market, by disease type, 2014 - 2025 (USD Million)

The initial symptoms witnessed due to enteric disease conditions are abdominal cramps, vomiting, nausea and anorexia which may lead to severe conditions such as heavy loss of fluids and essential nutrients from the body. Pediatric and geriatric age groups are more prone to these conditions owing to their weak immune system. As per Bill and Melinda Gates Foundation, 500,000 young children under the age of 5 die per annum because of enteric and diarrheal diseases, primarily in developing nations. The mild initial symptoms are at times ignored and act as a constraint for this market.

Enteric diseases are a major cause of morbidity and mortality over the globe with increasing prevalence in developing countries, as these regions have poor drainage and sanitation facilities. It is estimated that developing nations account for more than 85% of these infections in terms of incidence and epidemiology.

Disease Type Insights

Key segments based on disease type are bacterial, viral and parasitic enteric diseases. Various bacteria that cause these diseases include C. difficile, E. coli, Shigella, Salmonella and Campylobacter. These form majority of the market with 66.21% of revenue share in 2016 whereas viral enteric disease testing market held substantial share.

Over the next seven years, parasitic diseases testing is expected to witness significant growth owing to rising incidences of such infections and emergence of new parasitic strains. According to the WHO, cholera is estimated to affect 1,72,454 people worldwide per year resulting into increasing mortality rate. The WHO further states that in the Asian and American countries, number of countries reporting cholera cases, have been significantly reduced compared to 2011.

The Child Health Epidemiology Research Group (CHERG), enteric pathogens such as Salmonella spp., Rotavirus and V. cholera caused more mortality as compared to other enteric pathogen and thus the WHO committee has given the highest priority to the development of new and improved vaccines against these pathogens. Even if some viruses are geographically ubiquitous, such as rotavirus, which infects about 90 percent of the population of the world younger than five years of age, most of the times infections are environmentally determined along with restricted seasonal and geographical patterns that are related to hygiene and degree of sanitation and access to clean drinking water

Regional Insights

Regionally, the market is segmented into North America, Europe, Asia Pacific, Latin America and MEA. North America dominated the market in term of revenue share with over 28.57% of share in 2016 and is expected to grow at a CAGR of 1.6% over the forecast period. Attractive regions for the market are placed in developing nations such as China, India thereby promoting fastest growth for Asia Pacific. Asia Pacific is expected to gain 27.29% of the market share by 2025 owing to rising awareness level among people for testing and increasing infections.

Competitive Insights

Major share of the enteric disease testing market is held by companies such as Alere Inc, Bio Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid, DiaSorin, Meridian BioSciences and Coris BioConcept.

The players are involved in technological advancement and new product development in order to sustain their position in market and offer cost-efficient solutions. For instance, in November 2014, BioMerieux launched VITEK 2 compact. The reduction in size of the product increases market scope by installation of these in laboratories of all sizes. Furthermore, the upgraded technology enhances performance.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. F-or the purpose of this study, Grand View Research has segmented the global enteric disease testing market on the basis of disease type and region:

• Type Outlook (Revenue, USD Million, 2014 - 2025)

  • Bacterial enteric disease

    • C. difficile

    • Campylobacteriosis

    • Cholera

    • E. coli

    • H. pylori

    • Salmonellosis

    • Shigellosis

  • Viral enteric disease

    • Rotavirus

    • Norovirus

  • Parasitic enteric disease

    • Amebiasis

    • Cryptosporidiosis

    • Giardiasis

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • Middle East Asia

    • South Africa